News | 30 November 2012
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain. Bartlett was left with ...
Click on the link to read the full article at Reuters UK
(This link will open in a new window)